Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
83
TGA:83
Drug Approvals
OMNIPAQUE 300 iohexol 323.5 g/500 mL solution for injection bottle (348754)
- Product Name
- OMNIPAQUE 300 iohexol 323.5 g/500 mL solution for injection bottle
- Approval Date
- Nov 10, 2021
TGA
OMNIPAQUE 350 iohexol 377.5 g/500 mL solution for injection bottle (348758)
- Product Name
- OMNIPAQUE 350 iohexol 377.5 g/500 mL solution for injection bottle
- Approval Date
- Nov 10, 2021
TGA
CLARISCAN gadoteric acid 2.793g/10mL solution for injection pre-filled syringe (284860)
- Product Name
- CLARISCAN gadoteric acid 2.793g/10mL solution for injection pre-filled syringe
- Approval Date
- Jan 11, 2018
TGA
CLARISCAN gadoteric acid 5.586g/20mL solution for injection vial (290161)
- Product Name
- CLARISCAN gadoteric acid 5.586g/20mL solution for injection vial
- Approval Date
- Jan 11, 2018
TGA
CLARISCAN gadoteric acid 1.397g/5mL solution for injection vial (284859)
- Product Name
- CLARISCAN gadoteric acid 1.397g/5mL solution for injection vial
- Approval Date
- Jan 11, 2018
TGA
CLARISCAN gadoteric acid 4.190g/15mL solution for injection pre-filled syringe (290159)
- Product Name
- CLARISCAN gadoteric acid 4.190g/15mL solution for injection pre-filled syringe
- Approval Date
- Jan 11, 2018
TGA
CLARISCAN gadoteric acid 2.793g/10mL solution for injection vial (290160)
- Product Name
- CLARISCAN gadoteric acid 2.793g/10mL solution for injection vial
- Approval Date
- Jan 11, 2018
TGA
VISIPAQUE iodixanol 13.0g/20mL (652mg/mL) injection vial (154370)
- Product Name
- VISIPAQUE iodixanol 13.0g/20mL (652mg/mL) injection ampoule
- Approval Date
- Oct 29, 2008
TGA
VISIPAQUE iodixanol 11.0g/20mL (550mg/mL) injection vial (154369)
- Product Name
- VISIPAQUE iodixanol 11.0g/20mL (550mg/mL) injection vial
- Approval Date
- Oct 29, 2008
TGA
VISIPAQUE iodixanol 27.5g/50mL (550mg/mL) injection ampoule (75925)
- Product Name
- VISIPAQUE iodixanol 27.5g/50mL (550mg/mL) injection ampoule
- Approval Date
- Nov 30, 2000
TGA
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
Clinical Trials
No trials found
News
Asimov Expands Strategic Partnerships to Accelerate Biologics Development Through CHO Edge Platform
Asimov has formed strategic partnerships with Cytiva and LOTTE BIOLOGICS to integrate its CHO Edge cell line development platform with established biomanufacturing capabilities.